GLSHQ — Gelesis Holdings Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $65.64m
- $25.77m
Annual balance sheet for Gelesis Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Cash and Equivalents | |||
Short Term Investments | |||
Cash and Short Term Investments | 72.1 | 28.4 | 7.41 |
Net Total Accounts Receivable | |||
Net Total Receivables | 8.93 | 9.9 | 4.59 |
Total Inventory | |||
Prepaid Expenses | |||
Total Current Assets | 92.9 | 66 | 23.5 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 49.1 | 60.5 | 60.9 |
Net Intangible Assets | |||
Other Long Term Assets | |||
Total Assets | 164 | 146 | 103 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 17.5 | 102 | 78.3 |
Long Term Debt | |||
Total Long Term Debt | |||
Total Debt | |||
Minority Interest | |||
Total Other Liabilities | |||
Total Liabilities | 97.3 | 165 | 128 |
Redeemable Preferred Stock | |||
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Other Equity | |||
Total Equity | 66.6 | -18.2 | -25.1 |
Total Liabilities & Shareholders' Equity | 164 | 146 | 103 |
Total Common Shares Outstanding |